{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:20:31Z","timestamp":1791231631910,"version":"4.1.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00220","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:23:01Z","timestamp":1534724581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":222,"title":["The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations"],"prefix":"10.3389","volume":"5","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol Mech Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-4632.2009.04345.x","article-title":"Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania","volume":"49","author":"Baican","year":"2010","journal-title":"Int J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1365-4632.2004.02292.x","article-title":"Spectrum of autoimmune bullous diseases in Kuwait","volume":"43","author":"Nanda","year":"2004","journal-title":"Int J Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archderm.1995.01690200097021","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Wever","year":"1995","journal-title":"Arch Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland","volume":"153","author":"Gudi","year":"2005","journal-title":"Br J Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris - Incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"H\u00fcbner","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B14","first-page":"14","article-title":"What is a rare disease?","author":"EURORDIS","year":"2007","journal-title":"Rare Dis Eur."},{"key":"B15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1365-4632.2004.02533.x","article-title":"Pemphigus in the Mediterranean region of Turkey: a study of 148 cases","volume":"45","author":"Uzun","year":"2006","journal-title":"Int J Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ijd.13813","article-title":"Ethnic variations in the epidemiology of bullous pemphigoid in Israel","volume":"57","author":"Kridin","year":"2017","journal-title":"Int J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.03.014.","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e000181","DOI":"10.1136\/lupus-2016-000181","article-title":"Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002","volume":"3","author":"Brinks","year":"2016","journal-title":"Lupus Sci Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jnnp-2013-305450","article-title":"Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database","volume":"85","author":"Mackenzie","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1468-3083.2001.00275.x","article-title":"Bullous pemphigoid in Liguria: A 2-year survey","volume":"15","author":"Cozzani","year":"2001","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B27","first-page":"CR360","article-title":"Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005","volume":"13","author":"Serwin","year":"2007","journal-title":"Med Sci Monit."},{"key":"B28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.1985.tb02079.x","article-title":"Evidence of an association between bullous pemphigoid and psoriasis","volume":"113","author":"Grattan","year":"1985","journal-title":"Br J Dermatol."},{"key":"B31","unstructured":"WorldHealth Organization\n          Global Health Observatory (GHO): Data Repository. GHO2018"},{"key":"B32","first-page":"2015","article-title":"Mortality and life expectancy statistics","year":"2016","journal-title":"Mortal Life Expect Stat."},{"key":"B33","article-title":"Life expectancy at birth, total (years)","author":"World","year":"2015","journal-title":"World Dev Indic."},{"key":"B34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40520-015-0459-4","article-title":"Bullous pemphigoid and neurodegenerative diseases: a study in a setting of a Central European university dermatology department","volume":"28","author":"Pietkiewicz","year":"2016","journal-title":"Aging Clin Exp Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jdv.12995","article-title":"Neurological disorders in patients with bullous pemphigoid: clinical and experimental investigations","volume":"29","author":"Gambichler","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases - a case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000106574","article-title":"Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/bjd.12806","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre","volume":"170","author":"Cai","year":"2014","journal-title":"Br J Dermatol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.annder.2015.12.016","article-title":"Impact pronostique des maladies neurologiques au cours de la pemphigo\u00efde bulleuse: \u00e9tude r\u00e9trospective de 178 cas","volume":"143","author":"Chevalier","year":"2016","journal-title":"Ann Dermatol Venereol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"GBD","year":"2017","journal-title":"Lancet Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/ageing\/afq173","article-title":"Increasing prevalence of dementia among very old people","volume":"40","author":"Mathillas","year":"2011","journal-title":"Age Ageing"},{"key":"B46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrneurol.2016.32","article-title":"Epilepsy: Trends in new-onset epilepsy - The importance of comorbidities","volume":"12","author":"Sander","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/0284186X.2015.1115123","article-title":"Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012","volume":"55","author":"Dahlrot","year":"2016","journal-title":"Acta Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ane.12428","article-title":"Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades","volume":"132","author":"Grytten","year":"2015","journal-title":"Acta Neurol Scand."},{"key":"B50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000358174","article-title":"The increasing prevalence of multiple sclerosis in New Zealand","volume":"42","author":"Alla","year":"2014","journal-title":"Neuroepidemiology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/tan.12960","article-title":"A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?","volume":"89","author":"Amber","year":"2017","journal-title":"HLA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1365-2133.2009.09122.x","article-title":"Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain","volume":"160","author":"Li","year":"2009","journal-title":"Br J Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng0795-301","article-title":"The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1","volume":"10","author":"Brown","year":"1995","journal-title":"Nat Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.matbio.2005.11.004","article-title":"Collagen XVII is expressed in human CNS neurons","volume":"25","author":"Sepp\u00e4nen","year":"2006","journal-title":"Matrix Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cne.20549","article-title":"Collagen XVII and BP AG1 expression in the retina: Evidence for an anchoring complex in the central nervous system","volume":"487","author":"Claudepierre","year":"2005","journal-title":"J Comp Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0092-8674(95)90333-X","article-title":"Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration","volume":"81","author":"Guo","year":"1995","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","article-title":"Vildagliptin significantly increases the risk of bullous pemphigoid: a Finnish nationwide registry study","volume":"138","author":"Varpuluoma","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/15569527.2016.1211670","article-title":"A case of bullous pemphigoid induced by vildagliptin","volume":"36","author":"Keseroglu","year":"2017","journal-title":"Cutan Ocul Toxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamadermatol.2015.2939","article-title":"Bullous pemphigoid associated with linagliptin treatment","volume":"152","author":"Haber","year":"2016","journal-title":"JAMA Dermatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000443330","article-title":"Three cases of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors - one due to Linagliptin","volume":"232","author":"Mendon\u00e7a","year":"2016","journal-title":"Dermatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/fcp.12083","article-title":"Bullous pemphigoid induced by vildagliptin: a report of three cases","volume":"29","author":"B\u00e9n\u00e9","year":"2015","journal-title":"Fundam Clin Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.2337\/dc11-0804","article-title":"Dipeptidyl peptidase-4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases","volume":"34","author":"Pasmatzi","year":"2011","journal-title":"Diabetes Care"},{"key":"B65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jamadermatol.2013.1073","article-title":"A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors","volume":"149","author":"Aouidad","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3315\/jdcr.2014.1166","article-title":"Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature","volume":"8","author":"Attaway","year":"2014","journal-title":"J Dermatol Case Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case\u2013noncase study in the French Pharmacovigilance Database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":"Br J Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jcpt.12397","article-title":"Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database","volume":"41","author":"Garc\u00eda","year":"2016","journal-title":"J Clin Pharm Ther."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14957.","article-title":"Changing prevalence of diabetes mellitus in bullous pemphigoid: It is the dipeptidyl peptidase-4 inhibitors","author":"Gravani","year":"2018","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fimmu.2018.01030","article-title":"Gliptin accountability in mucous membrane pemphigoid induction in 24 out of 313 patients","volume":"9","author":"Gaudin","year":"2018","journal-title":"Front Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/1346-8138.14245","article-title":"Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid","volume":"45","author":"Chijiwa","year":"2018","journal-title":"J Dermatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/ijd.14005","article-title":"Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization","volume":"57","author":"Garc\u00eda-D\u00edez","year":"2018","journal-title":"Int J Dermatol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12877.","article-title":"Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: a retrospective study of 168 pemphigoid and 9,304 diabetes mellitus cases","author":"Kawaguchi","year":"2018","journal-title":"J Diabetes Investig."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors","volume":"138","author":"Ujiie","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.2741\/2785","article-title":"Dipeptidyl peptidase IV (DPP IV\/CD26) is a cell-surface plasminogen receptor","volume":"13","author":"Gonzalez-Gronow","year":"2008","journal-title":"Front Biosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/jid.2008.424","article-title":"Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97","volume":"129","author":"Hofmann","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4049\/jimmunol.181.2.1120","article-title":"Inhibition of CD26\/dipeptidyl peptidase IV Enhances CCL11\/eotaxin-mediated recruitment of eosinophils in vivo","volume":"181","author":"Forssmann","year":"2008","journal-title":"J Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/archderm.132.3.272","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jamainternmed.2016.9225","article-title":"Trends in central nervous system-active polypharmacy among older adults seen in outpatient care in the United States","volume":"177","author":"Maust","year":"2017","journal-title":"JAMA Intern Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40259-016-0204-3","article-title":"Immune-related adverse events associated with immune checkpoint inhibitors","volume":"30","author":"Day","year":"2016","journal-title":"Biodrugs"},{"key":"B84","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/ijd.13984","article-title":"A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors","volume":"57","author":"Lopez","year":"2018","journal-title":"Int J Dermatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/ddg.13411","article-title":"Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma","volume":"16","author":"Amber","year":"2018","journal-title":"J Dtsch Dermatol Ges."},{"key":"B86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1067\/mjd.2002.120445","article-title":"Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid","volume":"47","author":"Schmidt","year":"2002","journal-title":"J Am Acad Dermatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-4632.2004.02457.x","article-title":"Prodromal bullous pemphigoid","volume":"45","author":"Lamb","year":"2006","journal-title":"Int J Dermatol."},{"key":"B88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0190-9622(93)70179-W","article-title":"Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?","volume":"29","author":"Strohal","year":"1993","journal-title":"J Am Acad Dermatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/archderm.1979.04010030028010","article-title":"Localized pemphigoid simulating dyshidrosiform dermatitis","volume":"115","author":"Levine","year":"1979","journal-title":"Arch Dermatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2133.2002.465611.x","article-title":"Extensive erosive bullous pemphigoid: an atypical and serious clinical variant [11]","volume":"146","author":"Cordel","year":"2002","journal-title":"Br J Dermatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: a systematic review","volume":"78","author":"Lamberts","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/J.JID.2018.03.286","article-title":"280 Prevalence of pruritus and pemphigoid in nursing home residents (SSENIOR): a cross-sectional study of an unmet need","volume":"138","author":"Meijer","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jama.1967.03120220053008","article-title":"Basement zone antibodies in bullous pemphigoid","volume":"200","author":"Jordon","year":"1967","journal-title":"J Am Med Assoc."},{"key":"B95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/0190-9622(90)70094-X","article-title":"Direct immunofluorescence studies of sodium chloride\u2014separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita","volume":"22","author":"Kumar","year":"1990","journal-title":"J Am Acad Dermatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Bl\u00f6cker","year":"2012","journal-title":"Br J Dermatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1021\/ac500835k","article-title":"Paper-based ELISA for the detection of autoimmune antibodies in body fluid-the case of bullous pemphigoid","volume":"86","author":"Hsu","year":"2014","journal-title":"Anal Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"van","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/cup.12637","article-title":"Automated direct immunofluorescence analyses of skin biopsies","volume":"43","author":"Lemcke","year":"2016","journal-title":"J Cutan Pathol."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Dipeptidyl-peptidase IV inhibitors-associated bullous pemphigoid: estimating the risk of the new agents and characterizing the patients","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:23:15Z","timestamp":1534724595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":103,"alternative-id":["10.3389\/fmed.2018.00220"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00220","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"article-number":"220"}}